Chengdu Easton Biopharmaceuticals Co., Ltd. (688513.SS)

Home
688513.SS
Financials

40.64 (CNY) • At close June 6, 2025

Overview | Financials

Numbers are in millions (except for per share data and ratios) CNY.

	2025 Q1	2024 Q4	2024 Q3	2024 Q2	2024 Q1	2023 Q4	2023 Q3	2023 Q2	2023 Q1	2022 Q4	2022 Q3	2022 Q2	2022 Q1	2021 Q4	2021 Q3	2021 Q2	2021 Q1	2020 Q4	2020 Q3	2020 Q2	2020 Q1	2019 Q4	2019 Q3	2019 Q2	2019 Q1	2016 Q2	2016 Q1	2015 Q4	2015 Q2	2015 Q1
Revenue Numbers are in millions	305.64	309.818	370.423	349.109	314.99	266.854	294.422	277.505	277.853	272.923	322.18	306.456	268.954	249.499	274.735	277.453	221.248	249.163	237.795	258.55	176.41	269.033	202.874	264.472	210.856	60.818	60.818	60.28	56.09	56.09
Cost of Revenue Numbers are in millions	63.711	104.994	84.326	95.517	63.554	63.353	60.243	49.349	50.329	55.466	50.218	44.624	45.696	44.207	39.372	34.287	25.445	30.675	25.512	48.795	21.58	25.752	20.403	46.171	23.763	17.937	17.937	20.591	27.795	27.795
Gross Profit Numbers are in millions	241.929	204.824	286.098	253.592	251.436	203.501	234.179	228.156	227.524	217.457	271.962	261.832	223.258	205.293	235.363	243.167	195.803	218.487	212.283	209.755	154.83	243.281	182.471	218.302	187.094	42.882	42.882	39.689	28.295	28.295
Gross Profit Ratio Numbers are in millions	0.792	0.661	0.772	0.726	0.798	0.763	0.795	0.822	0.819	0.797	0.844	0.854	0.83	0.823	0.857	0.876	0.885	0.877	0.893	0.811	0.878	0.904	0.899	0.825	0.887	0.705	0.705	0.658	0.504	0.504
Reseach & Development Expenses Numbers are in millions	61.098	75.727	79.198	48.949	54.185	69.725	62.029	56.648	50.089	65.707	65.725	54.162	45.192	52.873	53.532	52.496	41.794	44.299	43.744	40.03	25.834	39.252	41.493	37.913	37.913	9.582	9.582	11.741	7.472	7.472
General & Administrative Expenses Numbers are in millions	21.742	-46.265	65.475	-13.287	20.869	-53.135	63.555	-14.769	23.125	-45.672	56.252	-7.99	16.385	-27.463	36.623	-6.116	14.005	-21.326	17.554	11.502	10.833	14.562	12.513	12.695	12.695	14.026	14.026	18.659	10.863	10.863
Selling & Marketing Expenses Numbers are in millions	110.616	23.046	153.902	120.924	115.644	97.43	96.609	87.851	102.672	108.31	132.836	115.956	117.036	115.844	130.242	118.468	103.548	140.37	115	128.353	88.33	149.516	126.147	129.799	129.799	14.58	14.58	11.533	6.311	6.311
SG&A Numbers are in millions	132.359	-23.219	219.377	142.482	136.513	44.294	160.163	73.082	125.796	62.638	189.088	107.966	133.421	88.381	166.866	112.351	117.553	119.044	132.555	141.139	99.163	164.077	138.66	143.905	143.905	28.593	28.593	30.197	17.154	17.154
Other Expenses Numbers are in millions	-13.997	131.888	-80.883	-0.491	-0.13	-234.393	0.059	-0	-6.521	46.7	-41.755	21.652	-2.094	7.973	-5.213	0.031	-0.025	0.262	-0.018	-144.653	-142.657	-0.711	1.999	-161.638	-180.439	0	0	0	0	0
Operating Expenses Numbers are in millions	179.46	184.396	214.136	191.923	175.958	234.393	175.199	161.291	169.364	175.046	213.057	183.78	176.519	184.28	160.899	181.215	155.416	168.515	169.186	-144.653	-142.657	233.687	168.081	-161.638	-180.439	28.645	28.645	29.81	17.906	17.906
Operating Income Numbers are in millions	62.469	20.428	71.961	61.669	80.221	32.461	66.741	76.423	68.278	49.682	64.634	88.974	57.338	37.943	80.186	79.13	46.895	56.107	43.833	65.102	33.753	12.657	14.994	56.664	30.418	13.236	13.236	8.717	10.22	10.22
Operating Income Ratio Numbers are in millions	0.204	0.066	0.194	0.177	0.255	0.122	0.227	0.275	0.246	0.182	0.201	0.29	0.213	0.152	0.292	0.285	0.212	0.225	0.184	0.252	0.191	0.047	0.074	0.214	0.144	0.218	0.218	0.145	0.182	0.182
Total Other Income Expenses Net Numbers are in millions	-0.057	0.791	-0.049	17.696	6.926	-2.276	0.059	-0	10.117	0.998	7.373	12.12	9.638	7.973	42.818	18.711	5.282	0.262	0.763	0.227	-0.186	55.852	1.999	-0.104	-0.004	1.073	1.073	1.186	0.307	0.307
Income Before Tax Numbers are in millions	62.413	21.219	71.913	78.678	80.091	32.344	66.8	76.423	68.24	50.68	65.134	88.866	57.308	45.915	74.973	79.162	46.87	56.369	43.815	65.329	33.537	11.945	16.993	56.56	30.414	14.309	14.309	9.903	10.526	10.526
Income Before Tax Ratio Numbers are in millions	0.204	0.068	0.194	0.225	0.254	0.121	0.227	0.275	0.246	0.186	0.202	0.29	0.213	0.184	0.273	0.285	0.212	0.226	0.184	0.253	0.19	0.044	0.084	0.214	0.144	0.235	0.235	0.164	0.188	0.188
Income Tax Expense Numbers are in millions	1.822	0.009	1.382	7.883	5.081	-2.681	4.605	5.887	7.254	-0.349	4.278	8.032	3.507	-0.436	6.24	5.111	3.578	3.068	5.031	154.29	-139.814	-1.737	1.264	186.529	-178.968	1.556	1.556	0.057	1.074	1.074
Net Income Numbers are in millions	60.59	21.211	70.531	71.482	75.01	32.858	62.194	70.536	60.986	51.028	60.856	80.834	53.802	46.352	68.732	74.051	43.292	53.3	38.785	55.382	30.694	13.682	15.729	50.258	28.943	12.753	12.753	9.96	9.452	9.452
Net Income Ratio Numbers are in millions	0.198	0.068	0.19	0.205	0.238	0.123	0.211	0.254	0.219	0.187	0.189	0.264	0.2	0.186	0.25	0.267	0.196	0.214	0.163	0.214	0.174	0.051	0.078	0.19	0.137	0.21	0.21	0.165	0.169	0.169
EPS Numbers are in millions	0.34	0.12	0.4	0.28	0.63	0.27	0.52	0.59	0.51	0.42	0.51	0.68	0.45	0.58	0.57	0.62	0.36	0.54	0.39	0.56	0.34	0.15	0.17	0.54	0.32	0.15	0.15	0.11	0.11	0.12
EPS Diluted Numbers are in millions	0.34	0.12	0.4	0.28	0.63	0.27	0.52	0.59	0.51	0.42	0.51	0.68	0.45	0.58	0.57	0.62	0.36	0.54	0.39	0.56	0.34	0.15	0.17	0.54	0.32	0.15	0.15	0.12	0.11	0.12
EBITDA Numbers are in millions	63.133	21.924	72.709	101.301	102.474	50.685	87.278	95.055	86.749	69.21	83.187	101.841	70.043	54.818	83.819	87.26	55.176	56.927	43.808	65.132	31.381	10.198	22.641	35.36	35.36	18.715	18.715	14.091	13.751	13.751
EBITDA Ratio Numbers are in millions	0.207	0.071	0.196	0.29	0.325	0.19	0.296	0.343	0.312	0.254	0.258	0.332	0.26	0.22	0.305	0.315	0.249	0.228	0.184	0.252	0.178	0.038	0.112	0.134	0.168	0.308	0.308	0.234	0.245	0.245

Chengdu Easton Biopharmaceuticals Co., Ltd.

SSE:688513.SS Add to watchlist

SSE:688513.SS